Page last updated: 2024-10-22

amiodarone and Hyperlipoproteinemia

amiodarone has been researched along with Hyperlipoproteinemia in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"To study the effect of hyperlipoproteinemia on in vitro distribution of amiodarone (AM) and its prevalent metabolite desethylamiodarone (DEA) in human and rat plasma."7.74The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma. ( Brocks, DR; Lee, SD; Shayeganpour, A; Wasan, KM, 2007)
"To study the effect of hyperlipoproteinemia on in vitro distribution of amiodarone (AM) and its prevalent metabolite desethylamiodarone (DEA) in human and rat plasma."3.74The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma. ( Brocks, DR; Lee, SD; Shayeganpour, A; Wasan, KM, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shayeganpour, A1
Lee, SD1
Wasan, KM1
Brocks, DR1

Other Studies

1 other study available for amiodarone and Hyperlipoproteinemia

ArticleYear
The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma.
    Pharmaceutical research, 2007, Volume: 24, Issue:4

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cholesterol; Humans; Hyperlipoproteinemias; Lipoprotein

2007